about
The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivoThe thyromimetic T-0681 protects from atherosclerosis.Phage-displayed recombinant single-chain antibody fragments with high affinity for cholesteryl ester transfer protein (CETP): cDNA cloning, characterization and CETP quantification.Hepatic ENPP1 expression is induced in diabetic rabbits.The resurgence of thyromimetics as lipid-modifying agents.Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1alpha- and basic FGF-dependent pathway in muscle cells.Cholesteryl ester transfer protein gene expression is not specifically regulated by CCAAT/enhancer-binding protein in HepG2-cells.The polyphenol PGG enhances expression of SR-BI and ABCA1 in J774 and THP-1 macrophages.Phospholipid transfer protein augments apoptosis in THP-1-derived macrophages induced by lipolyzed hypertriglyceridemic plasma.Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.Influence of aspirin on SR-BI expression in human carotid plaques.Cholesteryl ester transfer protein in patients with coronary heart disease.Quantification of low-density and high-density lipoproteins in human serum by material enhanced infrared spectroscopy (MEIRS).Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in men.Enhancement of cholesteryl ester transfer in plasma by hormone-replacement therapy.Molecular characterization of rabbit scavenger receptor class B types I and II: portal to central vein gradient of expression in the liver.Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I.The MTP -493TT genotype is associated with peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) Study.Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.Knockout of Apolipoprotein E in rabbit promotes premature intervertebral disc degeneration: A new in vivo model for therapeutic approaches of spinal disc disorders.The novel angiogenic cytokine secretoneurin promotes angiogenesis, arteriogenesis and vasculogenesis in the mouse hind-limb ischemia model.Effects of weight loss on lipid transfer proteins in morbidly obese women.Molecular characterization of rabbit phospholipid transfer protein: choroid plexus and ependyma synthesize high levels of phospholipid transfer protein.Expression, Purification, and Biochemical Characterization of Human Afamin.Insulin improves fasting and postprandial lipemia in type 2 diabetes.Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness.Leoligin, the major lignan from Edelweiss, inhibits 3-hydroxy-3-methyl-glutaryl-CoA reductase and reduces cholesterol levels in ApoE-/- mice.Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance.Scavenger receptor class B type I polymorphisms and peripheral arterial disease.Determinants of cholesterol efflux capacity in humans.Selective imaging of saturated and unsaturated lipids by wide-field CARS-microscopy.Pancreas transplantation modulates reverse cholesterol transport.Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failureHigh-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortalityDecreased cholesterol efflux capacity in patients with low cholesteryl ester transfer protein plasma levelsResearch update for articles published in EJCI in 2014The Taq1B-variant in the Cholesteryl Ester–Transfer Protein Gene and the Risk of Metabolic SyndromeCholesteryl Ester Transfer Protein in Metabolic Syndrome*
P50
Q24309200-9995CDF2-0FE6-4DA4-BCED-BF67AF678685Q30481717-89223BF1-02AD-4EFA-ABA4-0BB66E41A9A1Q33201460-C0881F4D-0654-4F28-9D78-EAA55DDB3528Q33253380-E0272C4E-4817-43ED-812D-4A4A42D6B4E2Q34356921-98F41E61-7EB4-4769-8258-8FB082B474F3Q38301740-6BDC5663-E448-4008-90AF-02D6E9797D20Q38320593-3ED76F2F-0364-48AB-8374-CCDA02F9FB73Q38839430-7DAA650C-821C-49E0-B38A-1485E471AE2DQ40175749-CAF5AB43-5F45-4EF6-BF47-6E1D92337BFFQ41507824-BB304716-9277-4373-8DBB-4D3137E0F20AQ42098692-0B220121-B155-4B98-8401-E9DEA326119EQ43055594-7D4F77C9-8316-45AD-AB80-E8C5066B5E52Q43244949-44FEC5E3-8687-4EB9-895C-3302C115447DQ43818618-0F81965B-3F19-417D-9BDA-F20D73311D08Q43973173-6F5699E0-2A40-45F5-94C5-73C62637D712Q44640532-610C440C-38D1-4F4F-BA44-B09E7BABFDD8Q45888775-58C945F1-355B-46F0-AD48-07ED323DC2E6Q46679327-176D89CD-FC9B-41EC-89AA-2F029E7749F5Q46714863-01BB5AC7-06CB-477D-9578-5275A8945B5AQ46813655-077A154E-35CF-43CA-B9F6-435EF0B6F2AEQ47098962-E9693031-6953-4CCD-A011-90B3627CB8BDQ47103253-38AC5F56-A441-47AC-9B29-D198FAC72D01Q47173065-A2EA2EE0-492B-4810-9316-450D1AB543E5Q48653975-E1983259-6860-43C9-95BD-1BCB9020311AQ50019288-318C90EB-2594-4341-A8EC-E56A7827968EQ51542445-B294ACC1-F85C-4196-8582-BC3149D25C93Q51585147-7E80F7B2-BD5A-4593-8386-72108FAED66BQ51587269-24795A8A-D5C3-40F1-89B8-E49A3AC7C61BQ51589940-2E2FABB2-3E18-417C-84C8-D8ABA8F8118EQ51630025-F8D140D6-A1F0-4756-ADD3-E6999CAAF5A7Q51747051-C5EBE2F2-EA3A-4423-B398-42B2CFA84FC0Q52740029-C644DF8B-4EAC-4BE0-8BEC-C66D23B7A80AQ53472384-AE453B39-4942-4043-9743-AFFDF5DA3ECDQ54073064-46C7C528-4EC2-4DFB-8EF7-B752563DF74CQ55982141-E1D19658-B127-4F5B-8F31-11DC322419CEQ57191836-FAAC6EB3-6375-42E4-A637-22BCDD391923Q57191836-FD30ACC6-B1F6-492C-AAB9-61C85D7EA08EQ57315966-7B2CFBBF-5E6C-4AA4-9039-518E11251D4AQ58197547-342B82C5-6999-4F99-BD4C-4E4BD9641425Q61451367-78E0D9CD-3742-42F4-8161-8DB6B24A23EC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andreas Ritsch
@ast
Andreas Ritsch
@en
Andreas Ritsch
@es
Andreas Ritsch
@nl
type
label
Andreas Ritsch
@ast
Andreas Ritsch
@en
Andreas Ritsch
@es
Andreas Ritsch
@nl
prefLabel
Andreas Ritsch
@ast
Andreas Ritsch
@en
Andreas Ritsch
@es
Andreas Ritsch
@nl
P106
P21
P31
P496
0000-0002-0417-5161